Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PredEver First: Prednisone and Everolimus for Chronic GvHD
NCT01862965Phase 2Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Mar 2013
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in chronic graft-versus-host disease (cGVHD), sponsored by University Medical Center Hamburg-Eppendorf. Started Mar 2013; status: completed.
02
Drugs
everolimus
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01862965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01862965.